Heteroaromatic NMDA receptor modulators and uses thereof
US10752633B2 · kind B2 · utility
8Cited by
3References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 8, 2019 |
| Grant date | Aug 25, 2020 |
| Priority date | — |
| Expiry date | Nov 8, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is 5-(3-chloro-4-fluorophenyl)-7-cyclopropyl-3-(2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl)-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one and pharmaceutically acceptable salts thereof, and their uses in the treatment of psychiatric, neurological, and neurodevelopmental disorders, as well as diseases of the nervous system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.